Short answer
Lexeo Therapeutics, Inc. (LXEO) filed an 8-K current report with the SEC on June 29, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders re-elected all three Class III directors through the 2029 annual meeting.
Lexeo Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders re-elected all three Class III directors through the 2029 annual meeting
- Brenda Cooperstone, M.D. received 48,792,570 votes for and 16,834,717 withheld
- R. Nolan Townsend and Paula HJ Cholmondeley each received more than 64.6 million votes for
- Stockholders ratified KPMG LLP as independent auditor for fiscal year ending December 31, 2026
- Auditor ratification passed with 75,497,386 votes for, 55,579 against, and 30,099 abstentions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Lexeo Therapeutics, Inc. 8-K filings
Get the next LXEO 8-K as it lands
Follow LXEO for push alerts, or ask the research agent what this filing means.